deferiprone has been researched along with ALS - Amyotrophic Lateral Sclerosis in 2 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Devos, D | 2 |
| Cabantchik, ZI | 2 |
| Moreau, C | 2 |
| Danel, V | 2 |
| Mahoney-Sanchez, L | 1 |
| Bouchaoui, H | 1 |
| Gouel, F | 2 |
| Rolland, AS | 1 |
| Duce, JA | 1 |
| Devedjian, JC | 2 |
| Grolez, G | 1 |
| Timmerman, K | 1 |
| Laloux, C | 1 |
| Petrault, M | 1 |
| Jonneaux, A | 1 |
| Dutheil, M | 1 |
| Lachaud, C | 1 |
| Lopes, R | 1 |
| Kuchcinski, G | 1 |
| Auger, F | 1 |
| Kyheng, M | 1 |
| Duhamel, A | 1 |
| Pérez, T | 1 |
| Pradat, PF | 1 |
| Blasco, H | 1 |
| Veyrat-Durebex, C | 1 |
| Corcia, P | 1 |
| Oeckl, P | 1 |
| Otto, M | 1 |
| Dupuis, L | 1 |
| Garçon, G | 1 |
| Defebvre, L | 1 |
| Duce, J | 1 |
| Bordet, R | 1 |
1 review available for deferiprone and ALS - Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Conservative iron chelation for neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Chelation Therapy; Deferiprone; Humans; Iron; Iron Chelating | 2020 |
1 trial available for deferiprone and ALS - Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Could Conservative Iron Chelation Lead to Neuroprotection in Amyotrophic Lateral Sclerosis?
Topics: Adult; Amyotrophic Lateral Sclerosis; Animals; Deferiprone; Disease Models, Animal; Dose-Response Re | 2018 |